Fighting tumours down to the last cancer cell
Researchers at PSI have developed a new drug that could increase the survival chances of patients with metastatic prostate cancer
06-Jul-2023 -
The drug is now being tested on patients in the PROGNOSTICS project. A research consortium consisting of the Paul Scherrer Institute, the University Hospital Basel and ETH Zurich is receiving two million Swiss francs in funding for this project.
In Switzerland, about 7100 men are diagnosed with ...
cancer
cancer drugs
metastases
+2